- Moneycontrol /
- Market /
- Hospitals & Medical Services /
- YEARLY RESULTS
BSE Live
Jan 21, 16:00Prev. Close
551.55
Open Price
555.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 21, 15:48Prev. Close
552.30
Open Price
552.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Yearly Results of Thyrocare Technologies (in Rs. Cr.) | Mar '19 | Mar '18 | Mar '17 | Mar '16 | Mar '15 | |
| Net Sales/Income from operations | 370.28 | 331.79 | 300.06 | 225.61 | 180.08 | |
| Other Operating Income | -- | -- | -- | 9.52 | -- | |
| Total Income From Operations | 370.28 | 331.79 | 300.06 | 235.14 | 180.08 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 103.25 | 88.07 | 78.38 | 59.66 | 48.66 | |
| Purchase of Traded Goods | 2.33 | 2.41 | 8.64 | 6.64 | 6.67 | |
| Increase/Decrease in Stocks | -0.26 | 0.37 | -0.86 | 0.68 | -0.10 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 40.51 | 32.49 | 29.35 | 24.29 | 17.26 | |
| Depreciation | 14.47 | 12.08 | 11.69 | 11.35 | 10.71 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 76.31 | 69.45 | 67.65 | 49.26 | 34.31 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 133.67 | 126.92 | 105.22 | 83.26 | 62.57 | |
| Other Income | 13.66 | 23.63 | 8.08 | 5.20 | 6.97 | |
| P/L Before Int., Excpt. Items & Tax | 147.33 | 150.56 | 113.30 | 88.46 | 69.54 | |
| Interest | 0.47 | 0.40 | -- | -- | -- | |
| P/L Before Exceptional Items & Tax | 146.86 | 150.16 | 113.30 | 88.46 | 69.54 | |
| Exceptional Items | -- | -2.19 | -- | 0.30 | 2.08 | |
| P/L Before Tax | 146.86 | 147.96 | 113.30 | 88.76 | 71.62 | |
| Tax | 51.63 | 51.93 | 38.45 | 30.00 | 23.17 | |
| P/L After Tax from Ordinary Activities | 95.23 | 96.04 | 74.85 | 58.75 | 48.45 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 95.23 | 96.04 | 74.85 | 58.75 | 48.45 | |
| Equity Share Capital | 52.80 | 53.72 | 53.72 | 53.72 | 50.54 | |
| Reserves Excluding Revaluation Reserves | 399.10 | 400.15 | 364.26 | 321.66 | 228.38 | |
| Equity Dividend Rate (%) | 200.00 | 100.00 | 100.00 | 100.00 | 37.58 | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 17.84 | 17.91 | 13.93 | 11.42 | 9.79 | |
| Diluted EPS | 17.80 | 17.85 | 13.91 | 11.41 | 9.79 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 17.84 | 17.91 | 13.93 | 11.42 | 9.79 | |
| Diluted EPS. | 17.80 | 17.85 | 13.91 | 11.41 | 9.79 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
